PEDIATRICS Vol. 75 No. 6 June 1985, pp. 1101-1104
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Czajka, P. A.
Right arrow Articles by Russell, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Czajka, P. A.
Right arrow Articles by Russell, S. L.

Nonemetic Effects of Ipecac Syrup

Peter A. Czajka PharmD1 and Steven L. Russell BS Pharm1

1 The Southern Poison Center, and University of Tennessee Center for the Health Sciences College of Pharmacy, Memphis

The aftereffects of home-induced emesis with ipecac syrup were determined by telephone interviews of callers to a poison center. During the 12-week study, the presence of any symptoms at follow-up in 146 patients was compared with findings in 99 callers to the poison center who did not receive ipecac. Within four hours after ipecac-induced emesis, 33.6% had no symptoms and 17.1% experienced protracted emesis. In the ipecac-treated group the incidences of one formed stool (4.1%) and lethargy during a typical sleeping time (42.5%) were not significantly different from the incidences in patients not receiving ipecac syrup. The incidences of diarrhea (13.0%) and atypical lethargy (11.6%) were higher (P < .025 and P < .05, respectively) after ipecac-induced emesis than in patients not receiving ipecac syrup. There was no significant statistical association between the propensity of the ingested toxin to produce diarrhea or lethargy and the occurrence of diarrhea or atypical lethargy. Because ipecac-induced emesis can produce diarrhea and lethargy, these side effects should be noted and differentiated from normal conditions when ipecac syrup is administered.

Key Words: poisoning • ipecac syrup • poison centers

Submitted on February 27, 1984
Accepted on June 21, 1984




This article has been cited by other articles:


Home page
 CirculationHome page
Part 14: First Aid
Circulation, December 13, 2005; 112(24_suppl): IV-196 - IV-203.
[Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Injury, Violence, and Poison Preventi
Poison Treatment in the Home
Pediatrics, November 1, 2003; 112(5): 1182 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Imashuku, S. Hibi, T. Ohara, A. Iwai, M. Sako, M. Kato, H. Arakawa, M. Sotomatsu, S. Kataoka, K. Asami, et al.
Effective Control of Epstein-Barr Virus-Related Hemophagocytic Lymphohistiocytosis With Immunochemotherapy
Blood, March 15, 1999; 93(6): 1869 - 1874.
[Abstract] [Full Text] [PDF]